CEDAR KNOLLS, NJ / ACCESSWIRE / December 17, 2019 / MYOS RENS Technology, Inc. ("MYOS" or "the Company") (NASDAQ:MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary ...
American College of Veterinary Pathologists Meeting (26th : 1975 : San Francisco, Calif.) siris_sil_1039554 ...
The MarketWatch News Department was not involved in the creation of this content. MYOS CORP, the sole owner and exclusive provider of FORTETROPIN, proudly announces the issuance of its 9th U.S. patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback